Publications & News

WilmerHale Serves as Counsel to Idera Pharmaceuticals in Public Offering of Common Stock

October 26, 2017

Idera Pharmaceuticals, Inc. announced the pricing of its underwritten public offering of 33,333,334 shares of its common stock at a public offering price of $1.50 per share. The company has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock. All of the shares in the offering are to be sold by Idera. The offering is expected to close on or about October 30, 2017, subject to customary closing conditions.

The WilmerHale team representing Idera in this transaction includes Stuart Falber, Ryan MittenessCaroline Dotolo and Jared Iverson.

View the press release.